Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – 9,10-seco- cyclopentanohydrophenanthrene ring system doai
Patent
1996-11-12
1999-03-09
Criares, Theodore J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
9,10-seco- cyclopentanohydrophenanthrene ring system doai
552653, A61K 3159, C07C40100
Patent
active
058801146
ABSTRACT:
A method for treating immune deficiency in a mammal by administering an amount of a vitamin D compound, such as Vitamin D.sub.3, its active form 1.alpha.,25-dihydroxyvitamin D.sub.3 or other compounds exhibiting vitamin D-like activity, to the mammal for a sufficient period of time to improve or restore the immunity of the mammal.
REFERENCES:
patent: 4749710 (1988-06-01), Truitt et al.
patent: 5190935 (1993-03-01), Binderup et al.
patent: 5206229 (1993-04-01), Calverley et al.
patent: 5225579 (1993-07-01), Tahara
patent: 5274142 (1993-12-01), Posner et al.
patent: 5447924 (1995-09-01), Bretting
Abe et al, "22-Oxa-1.alpha.,25-dihydroxyvitamin D.sub.3 : A new synthetic analogue of vitamin D having a potent immunoregularting activity without inducing hypercalcemia in mice", Calcium regulation and bone metabolism, pp. 146-151, 1990.
DeLuca Hector F.
Prahl Jean M.
Smith Connie M.
Yang Shouli
Criares Theodore J.
Wisconsin Alumni Research Foundation
LandOfFree
Treatment of immune deficiency with vitamin D compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of immune deficiency with vitamin D compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of immune deficiency with vitamin D compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1321309